Acrobiosystems (ABS HK): Synthetic Expert Call Transcript (03 Oct 2026)
Defensive Dual-Listing Dynamics: Acrobiosystems' resubmission of its H-share listing application on September 30, 2026, represents a defensive...
84 Views
IPO Databook: Acrobiosystems (301080 HK) - Sep 2026
Acrobiosystems is principally engaged in the research and development, production, and sales of recombinant proteins, antibodies, and analytical...
100 Views
Pre-IPO Acrobiosystems (A/H Listing) - The Business and the Outlook
ACROBIOSYSTEMS focus on recombinant proteins but needs to diversify product structure. Positive YoY growth suggests a performance turning...
194 Views
No more insights